At baseline, 118 clients (45.91%) presented with AHD (CD4 < 200 cells/μL), while only 39 (15.18%) had a last CD4 < 200 cells/μL. The gene discussed is CD4; the disease is mitochondrial DNA depletion syndrome 4a.